Carregant...

Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation

α7 nicotinic acetylcholine receptors (nAChRs) are relevant therapeutic targets for a variety of disorders including neurodegeneration, cognitive impairment, and inflammation. Although traditionally identified as an ionotropic receptor, the α7 subtype showed metabotropic-like functions, mainly linked...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Med Chem
Autors principals: Quadri, Marta, Silnović, Almin, Matera, Carlo, Horenstein, Nicole A., Stokes, Clare, De Amici, Marco, Papke, Roger L., Dallanoce, Clelia
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492555/
https://ncbi.nlm.nih.gov/pubmed/30342362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2018.10.015
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!